Home> Products> angiotensin receptor neprilysin inhibitor

{ "products": [ { "_id": "68b6d6c76f14ecfa6add5d56", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUSMART 200", "description": "Description: \nSACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.\n\nHeart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life.\n\n \nWhat is SACUSMART 200?\n \n\nSACUSMART 200 is a highly effective heart failure medication that combines two active components:\n\nSacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart.\n\nValsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II.\n\nTogether, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure.\n\n \nUses of SACUSMART 200\n \n\nSACUSMART 200 is prescribed for:\n\nChronic heart failure with reduced ejection fraction (HFrEF)\n\nReducing risk of hospitalization due to worsening heart failure\n\nImproving survival rates in patients with heart failure\n\nEnhancing exercise tolerance and quality of life in long-term heart failure management\n\n \nBenefits of SACUSMART 200\n \n\nDual action with neprilysin inhibition + ARB effect for comprehensive heart protection\n\nProven to reduce mortality and hospitalization risk in heart failure patients\n\nImproves symptoms such as breathlessness, fatigue, and swelling\n\nHelps patients regain better physical stamina and daily activity levels\n\nLong-term use significantly contributes to improved quality of life\n\n \nPossible Side Effects of SACUSMART 200\n \n\nWhile SACUSMART 200 is effective and generally well tolerated, some patients may experience:\n\nLow blood pressure (hypotension)\n\nIncreased blood potassium levels (hyperkalemia)\n\nDizziness or light-headedness\n\nKidney function changes\n\nCough\n\nRarely, serious allergic reactions or angioedema (swelling of face, lips, or throat)\n\nImmediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs.\n\n \nPrecautions Before Using SACUSMART 200\n \n\nDo not use if you are allergic to sacubitril, valsartan, or other ARBs\n\nAvoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema\n\nNot recommended for patients with a history of hereditary angioedema\n\nCaution in patients with severe kidney or liver disease\n\nPregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby\n\nAlways monitor blood pressure, kidney function, and potassium levels while on this treatment\n\n \nDrug Interactions\n \n\nSACUSMART 200 may interact with:\n\nACE inhibitors – should not be combined, risk of angioedema\n\nPotassium supplements or potassium-sparing diuretics – risk of high potassium\n\nNSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function\n\nLithium – risk of lithium toxicity\n\nDiuretics – may increase the risk of low blood pressure\n\nAlways inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200.\n\n \nConclusion\n \n\nSACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life.\n\nFor patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.", "price": 750.0, "discountamount": 225.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2170, "imageuri": "https://productimages.withfloats.com/actual/68b6d6c9c4087f14f55d7d23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b6d6c9c4087f14f55d7d23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-02T11:36:39.17Z", "updatedon": "2025-09-02T11:36:39.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-200/2170", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril and Valsartan Tablets (97 mg + 103 mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67122e4d3a73cc5cb26a04de", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sacubitril (12 mg), Valsartan (13 mg)", "description": "SACUSMART 25 is a potent medication used in the treatment of chronic heart failure. It combines two essential active ingredients, Sacubitril (12 mg) and Valsartan (13 mg), working synergistically to improve heart function and reduce the risk of hospitalization due to heart failure. This combination medication belongs to the class of drugs known as ARNI (Angiotensin Receptor-Neprilysin Inhibitors) and is widely prescribed to manage heart failure symptoms, enhance quality of life, and prolong survival in patients with reduced ejection fraction.\n\n \n\nKey Benefits:\n \n\nImproves Heart Function: SACUSMART 25 enhances the ability of the heart to pump blood more efficiently, reducing symptoms of heart failure such as breathlessness and fatigue.\n\nReduces Hospitalization Risk: By improving heart function and preventing fluid buildup, SACUSMART 25 significantly reduces the likelihood of heart failure-related hospitalizations.\n\nLowers Blood Pressure: The combination of Sacubitril and Valsartan effectively lowers blood pressure, which helps reduce the strain on the heart and prevent further complications.\n\nEnhances Quality of Life: By managing the symptoms of heart failure, SACUSMART 25 helps patients lead a more active and comfortable life.\n\nLong-term Survival: Studies show that the combination therapy of Sacubitril and Valsartan can improve survival rates in patients with chronic heart failure compared to traditional therapies.\n\n \n\nHow Does It Work?\n \n\nSACUSMART 25 works by targeting two critical pathways in the regulation of blood pressure and heart function:\n\nSacubitril’s Role: As a neprilysin inhibitor, Sacubitril prevents the breakdown of natriuretic peptides, which are proteins that promote blood vessel dilation, sodium excretion, and reduced blood pressure. This leads to a decreased workload on the heart, allowing it to function more efficiently and with less strain.\n\nValsartan’s Role: Valsartan, as an angiotensin II receptor blocker, inhibits the action of angiotensin II, a hormone responsible for vasoconstriction (narrowing of blood vessels). By blocking this effect, Valsartan helps blood vessels remain relaxed, improving blood flow and reducing blood pressure.\n\nTogether, these mechanisms improve cardiac function, reduce blood pressure, and enhance the overall cardiovascular health of patients with heart failure.\n\n \n\nDirections for Use:\n \nDosage: SACUSMART 25 should be taken exactly as prescribed by a healthcare provider, typically once or twice daily, depending on the severity of the heart condition.\n\nAdministration: The tablet should be swallowed whole with water, with or without food. It's important not to crush or chew the tablet as this could affect the release and absorption of the medication.\n\nMissed Dose: If a dose is missed, take it as soon as possible unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one.\n\nRegular Monitoring: Patients should regularly monitor their blood pressure and kidney function, as SACUSMART 25 can lower blood pressure significantly and may affect kidney health.\n\n \n\nSide Effects:\n \n\nWhile SACUSMART 25 is generally well-tolerated, some individuals may experience side effects. It’s important to be aware of these potential reactions and consult a doctor if they occur.\n\nCommon Side Effects:\nLow blood pressure (hypotension)\nDizziness or lightheadedness\nElevated potassium levels (hyperkalemia)\nCough\nFatigue\n", "price": 165.0, "discountamount": 49.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "blood flow", "less strain", "Key Benefits", "Cough Fatigue", "fluid buildup", "blood vessels", "kidney health", "survival rates", "heart function", "kidney function", "heart condition", "comfortable life", "cardiac function", "sodium excretion", "potent medication", "ejection fraction", "Long-term Survival", "Regular Monitoring", "Low blood pressure", "combination therapy", "potential reactions", "healthcare provider", "next scheduled dose", "Common Side Effects", "Hospitalization Risk", "natriuretic peptides", "traditional therapies", "chronic heart failure", "blood vessel dilation", "two critical pathways", "combination medication", "heart failure symptoms", "Elevated potassium levels", "overall cardiovascular health", "angiotensin II receptor blocker", "two essential active ingredients", "heart failure-related hospitalizations", "Angiotensin Receptor-Neprilysin Inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1995, "imageuri": "https://productimages.withfloats.com/actual/67122e531e1ad5a3231ccd27.png", "tileimageuri": "https://productimages.withfloats.com/tile/67122e531e1ad5a3231ccd27.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-18T09:45:49.363Z", "updatedon": "2024-10-18T09:45:49.363Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacubitril-12-mg-valsartan-13-mg-/1995", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SACUSMART 25 ", "category": "CARDIOLOGYRANGE", "tags": [ "Sacubitril/valsartan", "sacubitril/valsartan tablets 50 mg uses", "Sacubitril Valsartan brands in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66e17c18143af4c013225b9d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Eq . to Sacubitril 49 mg , Valsartan 51 mg", "description": "SACUSMART 10 is a combination medication that contains Sacubitril (49 mg) and Valsartan (51 mg), two potent active ingredients used primarily for managing heart failure. This combination is designed to improve heart function, lower the risk of hospitalization, and enhance the quality of life in patients with chronic heart failure by reducing the strain on the heart. SACUSMART 10 is often prescribed for individuals who need both blood pressure control and heart protection.\n\n \n\nKey Ingredients:\n \n\nSacubitril (49 mg): Sacubitril is a neprilysin inhibitor that helps in the dilation of blood vessels, promoting better blood flow and reducing the strain on the heart.\nValsartan (51 mg): Valsartan is an angiotensin II receptor blocker (ARB), which helps in lowering blood pressure by blocking the action of angiotensin, a substance that tightens blood vessels, leading to improved heart function and reduced hypertension.\n \n\nKey Benefits:\n \n\nImproves Heart Function: SACUSMART 10 is clinically proven to improve heart pumping efficiency in patients with heart failure.\nReduces Hospitalizations: It decreases the likelihood of heart failure-related hospital admissions by managing symptoms more effectively.\nBlood Pressure Management: Valsartan’s ARB action helps in lowering blood pressure, which further reduces the stress on the heart.\nSlows Disease Progression: By improving circulation and reducing the heart’s workload, SACUSMART 10 helps in delaying the progression of heart failure.\nEnhances Quality of Life: Patients often experience reduced symptoms such as shortness of breath and fatigue, allowing for a better quality of life.\n \n\nHow Does It Work?\n \n\nSACUSMART 10 works by combining two mechanisms:\n\nSacubitril inhibits neprilysin, an enzyme that breaks down substances like natriuretic peptides which dilate blood vessels and promote sodium excretion. This action helps reduce the blood pressure and the workload on the heart.\nValsartan, as an ARB, blocks the effects of angiotensin II, preventing blood vessel constriction and reducing blood pressure. Together, these actions improve blood flow, reduce strain on the heart, and help manage heart failure more effectively.\n \n\nDirections for Use:\n \n\nDosage: The dosage is determined by the healthcare provider based on the patient’s condition and medical history. It is typically taken orally, twice daily.\nWith or Without Food: SACUSMART 10 can be taken with or without food. Swallow the tablet whole with water.\nCompliance: For best results, take SACUSMART 10 consistently at the same time each day. Do not stop taking the medication without consulting your healthcare provider.\n \n\nSide Effects:\n \n\nWhile SACUSMART 10 is generally well-tolerated, some patients may experience side effects such as:\n\nDizziness or lightheadedness (especially when standing up too quickly)\nCough\nFatigue\nHypotension (low blood pressure)\nKidney function changes\nElevated potassium levels (hyperkalemia)", "price": 695.0, "discountamount": 208.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "51 mg", "49 mg", "same time", "ARB action", "blood flow", "Side Effects", "best results", "Key Benefits", "Cough Fatigue", "blood vessels", "heart function", "two mechanisms", "medical history", "Key Ingredients", "heart protection", "sodium excretion", "pumping efficiency", "low blood pressure", "Disease Progression", "healthcare provider", "neprilysin inhibitor", "natriuretic peptides", "chronic heart failure", "combination medication", "blood pressure control", "Kidney function changes", "Blood Pressure Management", "blood vessel constriction", "Elevated potassium levels", "two potent active ingredients", "angiotensin II receptor blocker", "heart failure-related hospital admissions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1975, "imageuri": "https://productimages.withfloats.com/actual/66e17c3be07f45ab843d840e.png", "tileimageuri": "https://productimages.withfloats.com/tile/66e17c3be07f45ab843d840e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-11T11:16:40.793Z", "updatedon": "2024-09-11T11:16:40.793Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/eq-to-sacubitril-49-mg-valsartan-51-mg/1975", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SACUSMART 100 ", "category": "CARDIOLOGYRANGE", "tags": [ "sacubitril and valsartan tablets", "sacubitril and valsartan tablets 50 mg", "sacubitril and valsartan", "sacubitril and valsartan tablets uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ee8be7b387b17ecbcbde3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " SACUBRIGHT 200 ", "description": "SACUBRIGHT 200 \nSacubitril (97mg), Valsartan (103mg)\nSACUBRIGHT 200 is a combination medication containing two active ingredients: Sacubitril (97mg) and Valsartan (103mg). This combination is designed to provide dual inhibition of the renin-angiotensin-aldosterone system (RAAS) for the treatment of heart failure with reduced ejection fraction (HFrEF).\n\nSacubitril is a neprilysin inhibitor, while Valsartan is an angiotensin II receptor blocker (ARB). Together, they work synergistically to improve cardiovascular outcomes in patients with HFrEF by targeting different pathways involved in the pathophysiology of heart failure.\n\nNeprilysin is an enzyme responsible for the degradation of natriuretic peptides, which play a crucial role in regulating blood pressure and fluid balance. By inhibiting neprilysin, Sacubitril increases the levels of natriuretic peptides, leading to vasodilation, natriuresis, and diuresis, which helps reduce blood pressure, preload, and afterload on the heart.\n\nValsartan, as an ARB, blocks the effects of angiotensin II, a vasoconstrictor and stimulator of aldosterone secretion. By antagonizing the angiotensin II type 1 (AT1) receptors, Valsartan dilates blood vessels, reduces blood pressure, and attenuates the deleterious effects of angiotensin II on cardiac remodeling and fibrosis.\n\nSACUBRIGHT 200 is indicated for the treatment of symptomatic HFrEF in patients with New York Heart Association (NYHA) class II-IV heart failure. Clinical studies have demonstrated that this combination therapy reduces the risk of cardiovascular death and hospitalization for heart failure compared to traditional therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) alone.\n\nAs with any medication, SACUBRIGHT 200 may cause side effects, including hypotension, hyperkalemia, renal impairment, and angioedema. Patients should be monitored regularly for these adverse effects, especially during initiation and dose titration.\n\nOverall, SACUBRIGHT 200 represents an innovative approach to the management of HFrEF, offering superior efficacy and cardiovascular benefits compared to standard therapy. However, it should only be used under the supervision of a healthcare professional experienced in the management of heart failure and in accordance with established treatment guidelines.\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/sacubright-200-134307\n\n\n\n", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ARB", "risk", "RAAS", "EMAIL", "Order", "levels", "diuresis", "fibrosis", "patients", "Valsartan", "stimulator", "initiation", "angioedema", "SACUBRIGHT", "accordance", "management", "Sacubitril", "natriuresis", "degradation", "information", "supervision", "hypotension", "sterisonline", "sterispharma", "hyperkalemia", "vasodilation", "side effects", "crucial role", "CALL/WHATSAPP", "fluid balance", "blood vessels", "dose titration", "AT1) receptors", "blood pressure", "dual inhibition", "adverse effects", "pathophysiology", "hospitalization", "vasoconstrictor", "standard therapy", "renal impairment", "Clinical studies", "symptomatic HFrEF", "superior efficacy", "different pathways", "cardiac remodeling", "combination therapy", "deleterious effects", "innovative approach", "traditional therapy", "treatment guidelines", "neprilysin inhibitor", "cardiovascular death", "natriuretic peptides", "angiotensin II type 1", "aldosterone secretion", "two active ingredients", "combination medication", "cardiovascular outcomes", "cardiovascular benefits", "healthcare professional", "reduced ejection fraction", "New York Heart Association", "angiotensin receptor blockers", "angiotensin II receptor blocker", "NYHA) class II-IV heart failure", "renin-angiotensin-aldosterone system", "angiotensin-converting enzyme (ACE) inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1279, "imageuri": "https://productimages.withfloats.com/actual/665ee8c06030c166b1a41ef3.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ee8c06030c166b1a41ef3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T10:13:18.717Z", "updatedon": "2024-06-04T10:13:18.717Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/-sacubright-200-/1279", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril (97mg), Valsartan (103mg)", "category": "CARDIOLOGYRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ed5007247ae19c48269ee", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUSMART 50", "description": "SACUSMART 50\nSacubitril (24mg), Valsartan (26mg)\nSACUSMART 50 is a combination medication containing Sacubitril (24mg) and Valsartan (26mg). This combination is primarily used for the treatment of heart failure. By reducing the strain on the heart, SACUSMART 50 helps to improve the overall quality of life for patients with chronic heart failure.\n\nUses\n\nHeart Failure Management: SACUSMART 50 is specifically designed to manage chronic heart failure. It works by relaxing blood vessels, improving blood flow, and reducing the workload on the heart.\nSymptom Relief: The medication helps in alleviating symptoms such as shortness of breath, fatigue, and fluid retention, commonly associated with heart failure.\nHow It Works\n\nSacubitril: Sacubitril inhibits neprilysin, an enzyme that breaks down natriuretic peptides. These peptides help to reduce blood pressure by promoting sodium excretion and dilating blood vessels.\nValsartan: Valsartan is an angiotensin II receptor blocker (ARB) that helps to lower blood pressure and prevent the narrowing of blood vessels, thus improving blood flow and reducing strain on the heart.\nDosage\n\nStarting Dose: The typical starting dose of SACUSMART 50 is one tablet twice a day. The dosage may be adjusted based on the patient's response and tolerance to the medication.\nMaintenance Dose: Depending on the effectiveness and side effects, the dose may be increased or maintained as prescribed by the healthcare provider.\nSide Effects\n\nCommon Side Effects: Dizziness, fatigue, low blood pressure, and elevated blood potassium levels.\nSerious Side Effects: Kidney problems, severe allergic reactions, and angioedema (swelling of the face, lips, tongue, or throat).\nPrecautions\n\nKidney Function: Regular monitoring of kidney function is essential while on SACUSMART 50.\nPotassium Levels: Monitoring of blood potassium levels is important to avoid hyperkalemia.\nPregnancy and Breastfeeding: SACUSMART 50 should not be used during pregnancy and breastfeeding unless specifically prescribed by a healthcare provider.\nInteractions\n\nMedications: SACUSMART 50 can interact with other medications such as ACE inhibitors, potassium supplements, and NSAIDs, potentially leading to adverse effects.\nAlcohol: Avoid alcohol consumption as it can enhance the blood pressure-lowering effects and increase the risk of side effects.\nPrice and Availability\n\nAvailability: SACUSMART 50 is available in most pharmacies and can be obtained with a prescription.\nPrice: The price may vary depending on the pharmacy and the region. It is advisable to check with local pharmacies for the most accurate pricing.\nConclusion\nSACUSMART 50 (Sacubitril 24mg, Valsartan 26mg) is a crucial medication for managing chronic heart failure. By combining the benefits of Sacubitril and Valsartan, it provides a comprehensive approach to reducing the symptoms and improving the quality of life for heart failure patients. Always consult a healthcare provider before starting or adjusting the dosage of SACUSMART 50 to ensure it is safe and effective for your condition.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/sacusmart-50-134202\n\n\n\n\n\n\n", "price": 495.0, "discountamount": 149.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ARB", "life", "Uses", "face", "risk", "lips", "Call", "Email", "Price", "enzyme", "region", "strain", "NSAIDs", "tongue", "Dosage", "breath", "throat", "fatigue", "benefits", "swelling", "symptoms", "response", "WhatsApp", "pharmacy", "workload", "treatment", "narrowing", "Valsartan", "SACUSMART", "shortness", "Dizziness", "condition", "Pregnancy", "tolerance", "neprilysin", "one tablet", "Sacubitril", "blood flow", "Conclusion", "angioedema", "Precautions", "information", "sterispharma", "hyperkalemia", "Availability", "prescription", "sterisonline", "effectiveness", "blood vessels", "Breastfeeding", "Symptom Relief", "ACE inhibitors", "Kidney problems", "adverse effects", "overall quality", "Kidney Function", "fluid retention", "most pharmacies", "sodium excretion", "local pharmacies", "accurate pricing", "Maintenance Dose", "other medications", "low blood pressure", "crucial medication", "Regular monitoring", "Common Side Effects", "healthcare provider", "alcohol consumption", "Serious Side Effects", "natriuretic peptides", "potassium supplements", "typical starting dose", "chronic heart failure", "comprehensive approach", "heart failure patients", "combination medication", "Interactions Medications", "Heart Failure Management", "severe allergic reactions", "blood pressure-lowering effects", "elevated blood potassium levels", "angiotensin II receptor blocker" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1275, "imageuri": "https://productimages.withfloats.com/actual/665ed502ff7d0247b24c6c36.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ed502ff7d0247b24c6c36.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T08:49:04.316Z", "updatedon": "2024-06-04T08:49:04.316Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sacusmart-50/1275", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril (24mg), Valsartan (26mg)", "category": "CARDIOLOGYRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "662b998cf7fe09029cbf4fe1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUBRIGHT 100 ", "description": "SACUBRIGHT 100 \nSacubitril (49mg), Valsartan (51mg)\nSACUBRIGHT 100 is a pharmaceutical blend containing Sacubitril at 49mg and Valsartan at 51mg. This unique combination offers dual benefits for heart health. Sacubitril works by inhibiting neprilysin, an enzyme that breaks down beneficial peptides, leading to increased levels of these peptides that help widen blood vessels and reduce blood pressure. Valsartan is an angiotensin receptor blocker (ARB) that relaxes blood vessels, further lowering blood pressure. Together, SACUBRIGHT 100 provides comprehensive support for individuals with heart failure, improving symptoms and enhancing quality of life.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 690.0, "discountamount": 207.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ARB", "life", "51mg", "49mg", "enzyme", "quality", "symptoms", "Valsartan", "neprilysin", "Sacubitril", "SACUBRIGHT", "individuals", "heart health", "heart failure", "blood vessels", "dual benefits", "blood pressure", "increased levels", "unique combination", "beneficial peptides", "pharmaceutical blend", "comprehensive support", "angiotensin receptor blocker" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 766, "imageuri": "https://productimages.withfloats.com/actual/662b998e670596731f8d9f41.png", "tileimageuri": "https://productimages.withfloats.com/tile/662b998e670596731f8d9f41.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:09:48.199Z", "updatedon": "2024-06-07T12:31:55.667Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacubright-100-/766", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril (49mg), Valsartan (51mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "686e5df44c01bda1661052f0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ALFUGEM T 2.5/10", "description": "ALFUGEM T 2.5/10 is a scientifically formulated dual-action oral tablet that combines Alfuzosin 2.5 mg and Tadalafil 10 mg. This unique combination is primarily used for the treatment of benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) in men. By blending a selective alpha-blocker (Alfuzosin) with a phosphodiesterase-5 (PDE5) inhibitor (Tadalafil), ALFUGEM T 2.5/10 offers an effective solution for patients who suffer from both urological conditions.\n\nThe combination of alfuzosin and tadalafil has been shown to have an additive relaxant effect on human detrusor and prostatic tissues in vitro, enhancing urinary flow and improving sexual function.\n\nWhat is ALFUGEM T 2.5/10?\nALFUGEM T 2.5/10 is a fixed-dose combination tablet that contains two active ingredients:\n\nAlfuzosin (2.5 mg) – an alpha-1 adrenergic receptor blocker that relaxes the muscles in the prostate and bladder neck.\n\nTadalafil (10 mg) – a PDE5 inhibitor that increases blood flow to the penis and also helps relax the smooth muscles in the prostate and bladder.\n\nTogether, they help relieve lower urinary tract symptoms (LUTS) associated with BPH and improve erectile function in men.\n\nUses of ALFUGEM T 2.5/10:\nTreatment of Benign Prostatic Hyperplasia (BPH)\n\nRelief of lower urinary tract symptoms (LUTS) such as weak stream, urgency, and incomplete bladder emptying\n\nManagement of erectile dysfunction (ED) in men\n\nMay be beneficial for patients with both BPH and ED as a once-daily treatment\n\nHow Does ALFUGEM T 2.5/10 Work?\nAlfuzosin works by blocking alpha-1 receptors in the prostate and bladder, leading to relaxation of smooth muscle and improved urine flow.\n\nTadalafil enhances nitric oxide activity, leading to vasodilation in the penile tissues and also relaxes the lower urinary tract muscles.\n\nThe additive relaxant effect of this combination on the prostate and bladder tissues helps improve both urinary and sexual symptoms.\n\nSide Effects of ALFUGEM T 2.5/10:\nLike all medications, ALFUGEM T 2.5/10 may cause some side effects. Common side effects include:\n\nDizziness or lightheadedness\n\nHeadache\n\nBack pain or muscle aches\n\nNasal congestion\n\nIndigestion\n\nFlushing\n\nLow blood pressure (hypotension) in some cases\n\nRare but serious side effects may include:\n\nFainting or severe dizziness\n\nPriapism (prolonged or painful erection)\n\nVision changes or sudden vision loss\n\nChest pain or irregular heartbeat\n\nPrecautions Before Using ALFUGEM T 2.5/10:\nConsult your doctor before use if you have a history of heart disease, liver/kidney problems, or hypotension.\n\nAvoid activities like driving or operating machinery if you feel dizzy after taking the tablet.\n\nDo not take with other PDE5 inhibitors or alpha-blockers unless prescribed.\n\nLimit alcohol intake, as it can increase the risk of dizziness or low blood pressure.\n\nNot recommended for use in women or children.\n\nDrug Interactions – What Drugs Interact with ALFUGEM T 2.5/10?\nCertain drugs may interact with ALFUGEM T 2.5/10 and affect its effectiveness or increase the risk of side effects:\n\nAvoid or use with caution:\n\nNitrates (e.g., nitroglycerin) – can cause dangerous drops in blood pressure\n\nOther alpha-blockers – increased risk of hypotension\n\nAntifungals (e.g., ketoconazole, itraconazole)\n\nHIV protease inhibitors (e.g., ritonavir)\n\nAntibiotics (e.g., erythromycin, clarithromycin)\n\nBlood pressure medications – may enhance hypotensive effect\n\nGrapefruit juice – can alter the drug metabolism\n\nAlways inform your doctor about all the medications and supplements you are taking.\n\nConclusion:\nALFUGEM T 2.5/10 offers a comprehensive dual-action approach to managing two common male conditions – BPH and ED. With the clinically proven benefits of alfuzosin and tadalafil, this medication not only improves urinary flow and relieves prostate-related discomfort but also enhances sexual performance. Its synergistic relaxant effect on the bladder, prostate, and penile tissues makes it an ideal solution for men looking for convenience, efficacy, and improved quality of life.\n\nAlways follow your healthcare provider’s instructions for safe and effective use.", "price": 310.0, "discountamount": 93.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2143, "imageuri": "https://productimages.withfloats.com/actual/686e5df9e9241987c803df61.png", "tileimageuri": "https://productimages.withfloats.com/tile/686e5df9e9241987c803df61.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-09T12:17:56.999Z", "updatedon": "2025-07-09T12:17:56.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/alfugem-t-2-5-10/2143", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "alfuzosin and tadalafil", "category": "UROLOGYRANGE", "tags": [ "alfuzosin and tadalafil" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "682b219a6e1fabb425afe806", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SILODOSIA T 8/5", "description": "SILODOSIA T 8/5 is a powerful combination medication designed for the effective management of Benign Prostatic Hyperplasia (BPH) and associated urinary symptoms in men. By combining Silodosin (8 mg), a selective alpha-1 blocker, with Tadalafil (5 mg), a phosphodiesterase type 5 inhibitor, this dual-therapy tablet improves urinary flow and relieves symptoms such as frequent urination, incomplete bladder emptying, and urgency. It also provides added benefits for patients with concurrent erectile dysfunction (ED), offering a holistic approach to men's urological and sexual health.\n\nKey Ingredients\nSilodosin 8 mg\nAn alpha-1 adrenergic receptor antagonist that helps relax the muscles in the prostate and bladder neck, easing the flow of urine.\n\nTadalafil 5 mg\nA PDE5 inhibitor that enhances blood flow to the pelvic region and is primarily used to treat erectile dysfunction. It also helps reduce urinary symptoms in men with BPH.\n\nKey Benefits\nProvides rapid relief from lower urinary tract symptoms (LUTS) associated with BPH\n\nImproves urine flow by relaxing smooth muscles in the prostate and bladder neck\n\nReduces the need for frequent nighttime urination (nocturia)\n\nEnhances sexual function in men with coexisting erectile dysfunction\n\nImproves quality of life and confidence by addressing both urological and sexual issues\n\nOnce-daily dosing for convenience and better compliance\n\nHow Does It Work?\nSilodosin works by selectively blocking alpha-1 adrenergic receptors in the smooth muscles of the prostate and bladder neck. This causes the muscles to relax, allowing urine to pass more easily and reducing symptoms like urgency, frequency, and weak stream.\n\nTadalafil inhibits the PDE5 enzyme, increasing levels of cyclic GMP, which leads to relaxation of smooth muscles and improved blood flow. In the prostate and bladder, this relaxation helps relieve BPH symptoms, while also enhancing erectile function in men.\n\nTogether, these ingredients provide a synergistic effect that improves both urinary and sexual health outcomes.\n\nDirections for Use\nTake one tablet once daily, preferably at the same time each day\n\nSwallow the tablet whole with a glass of water\n\nCan be taken with or without food\n\nDo not crush or chew the tablet\n\nFollow your physician’s advice regarding the duration of therapy\n\nDo not exceed the recommended dose\n\nSide Effects\nDizziness or light-headedness, especially when rising from a sitting or lying position\n\nHeadache\n\nBack pain or muscle aches\n\nNasal congestion\n\nDiarrhea or digestive discomfort\n\nEjaculation disorders (e.g., retrograde ejaculation)\n\nFlushing or warmth in the face\n\nRarely, priapism (prolonged erection) may occur—seek immediate medical attention if this happens\n\nVisual disturbances or blurred vision (in rare cases)\n\nIf you experience any severe or persistent side effects, consult your doctor immediately.", "price": 475.0, "discountamount": 143.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet follow", "urgency frequency", "mens urological", "urinary symptoms", "doctor immediately", "rare cases", "blurred vision", "visual disturbances", "medical attention", "physicians advice", "day swallow", "daily preferably", "synergistic effect", "ingredients provide", "cyclic gmp", "reducing symptoms", "rapid relief", "pelvic region", "pde5 inhibitor", "holistic approach", "relieves symptoms", "tadalafil 5 mg", "effective management", "smooth muscles", "helps relax", "added benefits", "bladder neck", "relaxing smooth muscles", "bladder neck reduces", "bladder neck easing", "improved blood flow", "enhances blood flow", "relax allowing urine", "bph key benefits", "retrograde ejaculation flushing", "enhancing erectile function", "work silodosin works", "treat erectile dysfunction", "selective alpha1 blocker" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2121, "imageuri": "https://productimages.withfloats.com/actual/682b21a0841d4ed84394ee61.png", "tileimageuri": "https://productimages.withfloats.com/tile/682b21a0841d4ed84394ee61.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-19T12:18:34.175Z", "updatedon": "2025-05-19T12:19:25.517Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/silodosia-t-8-5/2121", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Silodosin 8mg, Tadalafil 5 mg", "category": "UROLOGYRANGE", "tags": [ "Can silodosin and tadalafil be taken together", "Silodosin uses", "tadalafil 5mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68272992e579986392b124bf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NINTEPRIDE 150", "description": "NINTEPRIDE 150 is a prescription medication that contains Nintedanib 150 mg, a targeted therapy used primarily in the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and certain types of non-small cell lung cancer (NSCLC). It works by slowing the progression of fibrotic diseases, helping to maintain better lung function and improving the patient's quality of life.\n\nKey Ingredient\nNintedanib (150 mg)\nNintedanib is a tyrosine kinase inhibitor that blocks several growth factor receptors responsible for promoting fibrosis and tumor growth. It is an orally administered compound used in chronic and progressive lung conditions.\n\nKey Benefits\nHelps slow down the progression of idiopathic pulmonary fibrosis (IPF).\n\nImproves lung function and delays further decline in lung capacity.\n\nUsed as a treatment for systemic sclerosis-associated interstitial lung disease (SSc-ILD).\n\nBeneficial in certain types of advanced non-small cell lung cancer (NSCLC).\n\nTargets multiple pathways involved in fibrosis and tumor progression.\n\nProvides a convenient oral dosage form for chronic conditions.\n\nHow Does It Work?\nNINTEPRIDE 150 (Nintedanib 150 mg) works by inhibiting multiple receptor tyrosine kinases, including those for platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). These growth factors are responsible for the development and progression of fibrosis and abnormal cell proliferation. By blocking these receptors, Nintedanib helps to:\n\nReduce the formation of scar tissue in the lungs.\n\nDecrease inflammation and tissue remodeling.\n\nInhibit tumor angiogenesis in certain cancer types.\n\nPreserve lung structure and function over time.\n\nDirections for Use\nNINTEPRIDE 150 should be taken orally, twice daily (usually one capsule in the morning and one in the evening).\n\nTake the capsule with food and water to reduce the risk of gastrointestinal side effects.\n\nDo not chew or crush the capsule; swallow it whole.\n\nTake the medication at the same times each day for optimal results.\n\nFollow the dosage and schedule prescribed by your healthcare provider.\n\nIf a dose is missed, skip it and continue with the next scheduled dose. Do not take a double dose.\n\nSide Effects\nNINTEPRIDE 150 may cause some common and serious side effects. It is important to report any persistent or severe symptoms to a healthcare professional.\n\nCommon Side Effects:\n\nDiarrhea\n\nNausea\n\nVomiting\n\nLoss of appetite\n\nWeight loss\n\nAbdominal pain\n\nLiver enzyme elevation\n\nSerious Side Effects:\n\nSevere liver problems\n\nBleeding complications\n\nGastrointestinal perforation\n\nHeart-related issues such as increased blood pressure or myocardial infarction\n\nHypersensitivity reactions including rash, itching, or swelling\n\nRegular liver function monitoring and clinical follow-up are essential while on NINTEPRIDE 150 to ensure safe and effective use.", "price": 1050.0, "discountamount": 315.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "nintepride 150", "tumor progression", "capsule swallow", "promoting fibrosis", "nintepride 150nintepride 150", "scheduled dose", "chronic conditions", "lung function", "prescription medication", "ensure safe", "clinical followup", "rash itching", "severe symptoms", "missed skip", "healthcare provider", "schedule prescribed", "time directions", "scar tissue", "growth factors", "lung capacity", "tumor growth", "patients quality", "targeted therapy", "nintedanib 150 mg", "side effects", "gastrointestinal side effects", "orally administered compound", "receptors nintedanib helps", "increased blood pressure", "optimal results follow", "lungs decrease inflammation", "abnormal cell proliferation", "tyrosine kinase inhibitor", "fibrotic diseases helping" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2116, "imageuri": "https://productimages.withfloats.com/actual/682729941972da8c8f537bca.png", "tileimageuri": "https://productimages.withfloats.com/tile/682729941972da8c8f537bca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-16T12:03:30.781Z", "updatedon": "2025-05-16T12:03:30.781Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nintepride-150/2116", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Nintedanib 150mg", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }